Researchers at the RIKEN Center for Developmental Biology (CDB) have successfully transplanted retinal pigment cells derived from stem cells of one monkey into the eyes of other monkeys without rejection and without the need for immunosuppressant drugs. Published in Stem Cell Reports, the study shows that this procedure is possible as long as a set of cells called the MHC are genetically matched between the host monkey and the new retinal cells.
A realistic hope of modern medicine is to replace damaged tissue with healthy cells grown in the lab. Currently, adult cells can be reprogrammed into stem cells, and then re-differentiated and grown into desired cell types. The researchers at RIKEN CDB led by Masayo Takahashi have already begun a clinical transplant trial in people with age-related macular degeneration. The team grew retinal pigment cells from induced pluripotent stem cells (iPSCs) and transplanted them into the damaged retina of a human participant. In order to avoid tissue rejection, they used autologous iPSCs—iPSCs that were created from the recipient’s own skin cells.
While this method is sound, producing autologous iPSCs is costly. Additionally, because the cells must grow at the same rate as they do during normal development, a person would have to wait more than a year before a transplant could be performed.
Notes lead author Sunao Sugita, “In order to make iPSC transplantation a practical reality, the current goal is to create banks of iPSC-derived tissues that can be transplanted into anyone as they are needed. However, immune responses and tissue rejection are big issues to overcome when transplanting tissue derived from other individuals.”
The new study tested a technique called MHC matching as a way to overcome this issue. Major histocompatibility complexes (MHCs) are a sets of cell-surface proteins found in all cells that function in the immune system. In humans, MHCs are also called human leukocyte antigens (HLAs). There are many genetic variations of MHCs, and after transplantation, if the MHCs of the transplanted cells are not recognized by the T cells of the host immune system, there is an immune response and the tissue is rejected.
To test whether MHC matching is a viable method, the team used retinal pigment cells that were grown from monkey iPSCs in the iPS cell bank at the Center for iPS Cell Research and Application, Kyoto University. They transplanted the cells into the subretinal space in monkeys with either genetically matched or non-matched MHCs.
The researchers found that these transplanted cells survived without rejection for at least 6 months in MHC-matched monkeys, without using any of the usually necessary immunosuppressant drugs. In contrast, rejection was relatively quick in the MHC-mismatched monkeys. Immunohistochemical examination showed that infiltration by inflammatory cells was only present in the transplanted grafts of MHC-mismatched monkeys. In vitro, the team saw that T cells failed to respond to the iPSC-derived retinal pigment cells if they were from an MHC-matched monkey.
In a separate study published in the same issue of Stem Cell Reports, the researchers saw similar results when they repeated this last experiment with human T cells and HLA-matched or unmatched retinal pigment cells grown from IPSCs.
Now that we have established the lack of immune response in monkeys and in human cells in vitro,” explains Sugita, “using the iPS cell bank appears to be a viable solution, at least in the case of retinal pigment epithelial cell transplantation.”
“In the next clinical trial,” continues Sugita, “we plan to use allogeneic iPS-retinal pigment epithelial cells from HLA homozygote donors. The clinical data after the transplantation will allow us to see if the iPS cell bank is truly useful or not. If so, I think this type of transplantation can become standard treatment within 5 years.”
The Latest on: iPSC transplantation
[google_news title=”” keyword=”iPSC transplantation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: iPSC transplantation
- Historical Perspective of Transplantationon February 26, 2024 at 4:00 pm
The early focus of transplantation was technical -- replacing lost limbs and teeth, reconstructive surgery, transferring a body part from one animal to another. By the 20th century, the focus had ...
- Heart Transplantation for a Prisoneron February 24, 2024 at 4:00 pm
Stanford University Medical Center has received some recent press coverage centered around a controversial decision to provide a heart transplant to a convicted felon serving time in the ...
- Woman, 26, Recovers from 3rd Double Lung Transplant in 8 Years: ‘I Was Getting Another Chance’on February 23, 2024 at 12:37 pm
“I’m only 25, I don’t want to die yet. I’ve still got so much fight in me,” the woman said of deciding to get a third double lung transplant Kimberlee Speakman is a digital writer at PEOPL ...
- A Double Standard on Transplant Testson February 22, 2024 at 3:20 pm
It was a blow to transplant patients, who lost access to a noninvasive option that raises the likelihood of maintaining the health of their new organs.
- AGA guideline endorses fecal microbiota transplant as treatment for recurrent C. diff infectionon February 20, 2024 at 4:00 pm
diff) infection. Using fecal microbiota transplant, we take stool from a healthy donor and transfer it to the colon of the person with recurrent C. diff, restoring balance to their gut microbiome.
- Meet the Cambridge company developing gene-edited pigs for transplantationon February 19, 2024 at 4:00 pm
A Cambridge biotech company is taking new steps to advance the field of xenotransplantation — the transplantation of living organs, tissues, or cells from one species to another. EGenesis is ...
- Chrissy Teigen Got an Eyebrow Transplant – Here's What to Know About the Cosmetic Procedureon February 16, 2024 at 7:05 am
Chrissy Teigen underwent eyebrow transplant surgery in November 2021 to create a fuller, fluffier look — and, of course, she shared the "crazy" results with her social media followers.
- Breaking through new research barriers with iPSC technologyon February 14, 2024 at 4:00 pm
In this interview, we speak to Keith Olson and Coby Carlson from FUJIFILM Cellular Dynamics about their iPSC technology and how it is making breakthroughs in blood-brain barrier research.
- All Factors to Consider for Hair Transplant Turkey Cost in 2024on February 13, 2024 at 8:07 am
Fortunately, there is a solution that can restore a full head of hair and transform your overall look – hair transplant surgery. If you are considering a hair transplant in Turkey with ...
via Bing News